Alonso Heredia

2.3k total citations
71 papers, 1.6k citations indexed

About

Alonso Heredia is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Alonso Heredia has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Virology, 44 papers in Infectious Diseases and 25 papers in Immunology. Recurrent topics in Alonso Heredia's work include HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (41 papers) and Immune Cell Function and Interaction (16 papers). Alonso Heredia is often cited by papers focused on HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (41 papers) and Immune Cell Function and Interaction (16 papers). Alonso Heredia collaborates with scholars based in United States, Nigeria and Spain. Alonso Heredia's co-authors include Robert Redfield, Charles E. Davis, Nhut Le, Robert C. Gallo, Lai‐Xi Wang, Robert R. Redfield, Olga Latinovic, Haijing Song, David M. Margolis and Joseph Bryant and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Alonso Heredia

68 papers receiving 1.6k citations

Peers

Countries citing papers authored by Alonso Heredia

Since Specialization

Citations

This map shows the geographic impact of Alonso Heredia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alonso Heredia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alonso Heredia more than expected).

Fields of papers citing papers by Alonso Heredia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alonso Heredia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alonso Heredia. The network helps show where Alonso Heredia may publish in the future.

Co-authorship network of co-authors of Alonso Heredia

This figure shows the co-authorship network connecting the top 25 collaborators of Alonso Heredia. A scholar is included among the top collaborators of Alonso Heredia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alonso Heredia. Alonso Heredia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity 2025 ·Vaccines ·(unknown), (unknown), (unknown), Alonso Heredia, Joel V. Chua	2
2	CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses 2025 ·Nature Communications ·Milankumar Patel, Sudipta Panja, (unknown), Pravin Yeapuri, (unknown), Santhi Gorantla, Linda Chang, Alonso Heredia, Piotr Walczak, (unknown), Samuel M. Cohen, Bhavesh D. Kevadiya, Howard E. Gendelman	3
3	Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice 2021 ·Journal of Translational Medicine ·(unknown), (unknown), Alonso Heredia, (unknown), Mohammad M. Sajadi, (unknown), Yutaka Tagaya, Francesca Benedetti, Habib O. Ramadhani, Frank Denaro, Arshi Munawwar, Joseph Bryant, Davide Zella, Marvin S. Reitz, Fabio Romerio, Olga Latinovic	5
4	Anti-HIV Activity of Standard Combined Antiretroviral Therapy in Primary Cells Is Intensified by CCR5-Targeting Drugs 2020 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Alonso Heredia, Yutaka Tagaya, Francesca Benedetti, Davide Zella, Marvin S. Reitz, Fabio Romerio, Olga Latinovic	5
5	Novel Chronic Mouse Model of Cerebral Cavernous Malformations 2020 ·Stroke ·(unknown), Minh Arnould, (unknown), Cécile Otten, Salim Abdelilah‐Seyfried, Alonso Heredia, Anne‐Louise Leutenegger, Markus Schwaninger, Elisabeth Tournier‐Lasserve, Gwénola Boulday	18
6	Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals 2019 ·Journal of Clinical Investigation ·Jana Blažková, Eric W. Refsland, Katherine E. Clarridge, Victoria Shi, J. Shawn Justement, Erin Huiting, Kathleen Gittens, Xuejun Chen, Stephen D. Schmidt, Cuiping Liu, Nicole A. Doria‐Rose, John R. Mascola, Alonso Heredia, Susan Moir, Tae‐Wook Chun	8
7	Suppression of Active HIV-1 Infection in CD34 ⁺ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs 2019 ·AIDS Research and Human Retroviruses ·Olga Latinovic, (unknown), Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, Robert Redfield	8
8	Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders 2019 ·Experimental and Molecular Pathology ·(unknown), Joseph Bryant, Alonso Heredia, Tapas K. Makar	38
9	Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models 2019 ·Journal of Visualized Experiments ·Federico Perdomo-Celis, Sandra Medina-Moreno, Alonso Heredia, Harry Davis, Joseph Bryant, Juan Carlos Zapata	4
10	Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice 2017 ·PLoS ONE ·Sandra Medina-Moreno, Thomas C. Dowling, Juan Carlos Zapata, Nhut Le, Edward A. Sausville, Joseph Bryant, Robert Redfield, Alonso Heredia	16
11	Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice 2015 ·Proceedings of the National Academy of Sciences ·Alonso Heredia, Nhut Le, Ronald B. Gartenhaus, Edward A. Sausville, Sandra Medina-Moreno, Juan Carlos Zapata, Charles E. Davis, Robert C. Gallo, Robert Redfield	79
12	Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc 2014 ·Antiviral Research ·Olga Latinovic, (unknown), Henryk Szmacinski, Joseph R. Lakowicz, Alonso Heredia, Robert R. Redfield	4
13	Enzymatic Glycosylation of Triazole‐Linked GlcNAc/Glc–Peptides: Synthesis, Stability and Anti‐HIV Activity of Triazole‐Linked HIV‐1 gp41 Glycopeptide C34 Analogues 2009 ·ChemBioChem ·Weitong Huang, (unknown), Alonso Heredia, (unknown), Floris P. J. T. Rutjes, Floris L. van Delft, Lai‐Xi Wang	34
14	HIV-1 natural viral suppressors: control of viral replication in the absence of therapy 2007 ·AIDS ·Mohammad M. Sajadi, Alonso Heredia, Nhut Le, (unknown), Robert Redfield	68
15	Abacavir and Mycophenolic Acid, an Inhibitor of Inosine Monophosphate Dehydrogenase, Have Profound and Synergistic Anti-HIV Activity 2006 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·David M. Margolis, Alonso Heredia, Jariyanart Gaywee, (unknown), George L. Drusano, Robert R. Redfield	1
16	Modification and structure–activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120 2005 ·Organic & Biomolecular Chemistry ·Jingsong Wang, Nhut Le, Alonso Heredia, Haijing Song, Robert Redfield, Lai‐Xi Wang	24
17	Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity 2004 ·Journal of Pharmaceutical Sciences ·Lai‐Xi Wang, Alonso Heredia, Haijing Song, Zhaojun Zhang, Biao Yu, Charles E. Davis, Robert Redfield	106
18	Synergistic Inhibition of HIV-1 in Activated and Resting Peripheral Blood Mononuclear Cells, Monocyte-Derived Macrophages, and Selected Drug-Resistant Isolates With Nucleoside Analogues Combined With a Natural Product, Resveratrol 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Alonso Heredia, Charles E. Davis, Robert Redfield	67
19	Evidence of HIV-2 Infection in Equatorial Guinea (Central Africa): Partial Genetic Analysis of a B Subtype Virus 1997 ·AIDS Research and Human Retroviruses ·Alonso Heredia, Alejandro Vallejo, Vincent Soriano, (unknown), (unknown), Jay S. Epstein, (unknown)	8
20	Interferon-γ Induces Resistance in Primary Monocytes against Human Immunodeficiency Virus Type-1 Infection 1994 ·Biochemical and Biophysical Research Communications ·Subhash Dhawan, Alonso Heredia, (unknown), L M Wahl, Jay S. Epstein, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact